Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease
Z M Younossi, G Guyatt, M Kiwi, N Boparai, D King, Z M Younossi, G Guyatt, M Kiwi, N Boparai, D King
Abstract
Background and aims: To develop and assess a disease specific instrument for measuring health related quality of life (HRQL) in patients with chronic liver disease (CLD).
Methods: Based on responses from 60 patients with chronic liver disease, from 20 liver experts, and from a Medline search of the literature, items potentially affecting the HRQL of these patients were identified. A separate sample of 75 patients identified which items they found problematic and rated their importance. Results were explored using factor analysis; domains were chosen and items placed within domains. Redundant questions were eliminated and the final questionnaire was pretested in 10 patients. Using this instrument, HRQL was assessed in a further 133 patients with various types and stages of liver disease.
Results: Patients, experts, and the literature search identified 156 items of potential importance. Of these, 35 proved important to over 50% of 75 respondents in the item reduction sample. The factor analysis suggested six domains. After eliminating redundancies, the Chronic Liver Disease Questionnaire (CLDQ) included 29 items in the following domains: fatigue, activity, emotional function, abdominal symptoms, systemic symptoms, and worry. In pretesting, patients found the CLDQ clear and easy to complete in 10 minutes. In another 133 patients, the CLDQ showed a gradient between patients without cirrhosis, Child's A cirrhosis, and those with Child's B or C cirrhosis. CLDQ has evidence for moderate reliability at six months and seems to be responsive.
Conclusion: The CLDQ is short, easy to administer, produces both a summary score and domain scores, and correlates with the severity of liver disease.
References
- Br J Surg. 1973 Aug;60(8):646-9
- Liver Transpl Surg. 1997 Mar;3(2):93-104
- J Chronic Dis. 1985;38(1):27-36
- CMAJ. 1986 Apr 15;134(8):889-95
- J Chronic Dis. 1987;40(2):171-8
- Fam Pract. 1987 Sep;4(3):226-34
- J Chronic Dis. 1987;40(12):1129-33
- Thorax. 1987 Oct;42(10):773-8
- Med Care. 1989 Mar;27(3 Suppl):S148-56
- Control Clin Trials. 1989 Dec;10(4):407-15
- Control Clin Trials. 1990 Feb;11(1):43-51
- Arch Intern Med. 1991 Aug;151(8):1521-6
- Transplant Proc. 1992 Feb;24(1):202
- Med Care. 1992 Jun;30(6):473-83
- Soc Sci Med. 1992 Oct;35(8):1003-14
- J Clin Epidemiol. 1992 Dec;45(12):1341-5
- Transplant Proc. 1993 Apr;25(2):1916-8
- J Clin Epidemiol. 1994 Jan;47(1):81-7
- Transplant Proc. 1994 Jun;26(3):1779
- Clin Ther. 1994 Mar-Apr;16(2):334-43; discussion 271-2
- Clin Transpl. 1993;:161-73
- Hepatology. 1998 Jan;27(1):209-12
- JAMA. 1995 Jan 4;273(1):59-65
- N Engl J Med. 1996 Mar 28;334(13):835-40
- Dig Dis Sci. 1996 Dec;41(12 Suppl):75S-80S
- Med Care. 1981 Aug;19(8):787-805
Source: PubMed